Derivation of induced pluripotent stem cells from human peripheral circulating T cells.

This unit describes a protocol for the generation of induced pluripotent stem (iPS) cells from human peripheral circulating T cells. Initially, human dermal fibroblasts and retroviral vectors were used to generate human iPS cells. Invasive approaches, such as skin biopsy, and genomic insertion of transgenes into the host genome are not appropriate for routine clinical application. Peripheral circulating T cells are readily available from blood samples of patients and healthy volunteers. For the efficient generation of human iPS cells, efficient introduction of the transgene into host cells is necessary. Using a combination of activated T cell culture and Sendai virus allows for the easy and efficient introduction of transgenes into activated T cells and the generation of human iPS cells without genomic integration of extrinsic genes. The T cell-derived iPS (TiPS) cells exhibit monoclonal T cell receptor (TCR) rearrangement in their genome, a hallmark of mature terminally differentiated T cells.

[1]  I. Ishida,et al.  Direct generation of induced pluripotent stem cells from human nonmobilized blood. , 2011, Stem cells and development.

[2]  Shinsuke Yuasa,et al.  Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. , 2010, Cell stem cell.

[3]  R. Jaenisch,et al.  Reprogramming of human peripheral blood cells to induced pluripotent stem cells. , 2010, Cell stem cell.

[4]  G. Church,et al.  Reprogramming of T cells from human peripheral blood. , 2010, Cell stem cell.

[5]  E. Nuwaysir,et al.  Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes , 2010, PloS one.

[6]  Mari Sasao,et al.  Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. , 2010, Tissue engineering. Part A.

[7]  C. Dang,et al.  Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. , 2009, Blood.

[8]  Stefan Wagner,et al.  Generation of induced pluripotent stem cells from human cord blood. , 2009, Cell stem cell.

[9]  Alessandra Giorgetti,et al.  Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. , 2009, Cell stem cell.

[10]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[11]  Deepak M. Gupta,et al.  Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells , 2009, Proceedings of the National Academy of Sciences.

[12]  K. Hochedlinger,et al.  Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells , 2009, Nature Genetics.

[13]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[14]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[15]  G. Daley,et al.  Generation of induced pluripotent stem cells from human blood. , 2009, Blood.

[16]  A. Consiglio,et al.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes , 2008, Nature Biotechnology.

[17]  J. Utikal,et al.  Reprogramming of Neural Progenitor Cells into Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2 Expression , 2008, Stem cells.

[18]  C. Lengner,et al.  Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency , 2008, Cell.

[19]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[20]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[21]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[22]  K. Sugimachi,et al.  Recombinant Sendai virus vectors for activated T lymphocytes , 2003, Gene Therapy.

[23]  D. Conner Mouse embryo fibroblast (MEF) feeder cell preparation. , 2001, Current protocols in molecular biology.

[24]  T. Hirata,et al.  A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and Expression , 2000, Journal of Virology.

[25]  T. Kakizoe,et al.  A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients. , 1993, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.